RIM
PRAH

Ranger Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ranger Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-149,629
Closed -$22.9M – 119
2021
Q1 		$22.9M Sell
149,629
-15,738
-10% -$2.14M 1.26% 39
2020
Q4 		$20.7M Sell
165,367
-5,624
-3% -$629K 1.09% 42
2020
Q3 		$17.3M Sell
170,991
-1,268
-0.7% -$129K 1.1% 40
2020
Q2 		$16.8M Sell
172,259
-237,387
-58% -$22.1M 1.15% 39
2020
Q1 		$34M Sell
409,646
-12,451
-3% -$1.21M 2.99% 7
2019
Q4 		$46.9M Buy
422,097
+38,829
+10% +$3.99M 3.09% 5
2019
Q3 		$38M Sell
383,268
-170,772
-31% -$17M 2.73% 8
2019
Q2 		$54.9M Sell
554,040
-5,605
-1% -$535K 3.74% 3
2019
Q1 		$61.7M Buy
559,645
+108,227
+24% +$11.3M 4.46% 2
2018
Q4 		$41.5M Sell
451,418
-7,224
-2% -$731K 3.39% 3
2018
Q3 		$50.5M Buy
458,642
+916
+0.2% +$95.4K 3.34% 3
2018
Q2 		$42.7M Sell
457,726
-177,633
-28% -$15.3M 2.99% 6
2018
Q1 		$52.7M Sell
635,359
-7,760
-1% -$689K 3.89% 4
2017
Q4 		$58.6M Sell
643,119
-31,030
-5% -$2.58M 4.3% 1
2017
Q3 		$51.4M Sell
674,149
-55,049
-8% -$4.16M 3.85% 1
2017
Q2 		$54.7M Sell
729,198
-13,810
-2% -$957K 3.9% 2
2017
Q1 		$48.5M Buy
743,008
+231
+0% +$13.6K 3.52% 1
2016
Q4 		$40.9M Buy
742,777
+127,052
+21% +$6.97M 2.91% 2
2016
Q3 		$34.8M Sell
615,725
-170,110
-22% -$8.34M 2.49% 4
2016
Q2 		$32.8M Buy
785,835
+74,317
+10% +$3.42M 2.02% 14
2016
Q1 		$30.4M Sell
711,518
-19,870
-3% -$840K 1.86% 18
2015
Q4 		$33.1M Sell
731,388
-44,474
-6% -$1.87M 1.95% 20
2015
Q3 		$30.1M Buy
775,862
+278,802
+56% +$11.2M 1.7% 29
2015
Q2 		$18.1M Buy
+497,060
New +$15.7M 0.88% 43

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Ranger Investment Management's PRAH Position: Q2 2021 in Review

Ranger Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 149,629 shares — an estimated $22.9M sold.

Ranger Investment Management first reported a position in PRAH in Q2 2015 and held it in 24 quarters. The position peaked at $61.7M in Q1 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Ranger Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ranger Investment Management sold 149,629 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $22.9M.
  • Ranger Investment Management first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 24 quarters.
  • Ranger Investment Management's PRA Health Sciences, Inc. position peaked at $61.7M in Q1 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Ranger Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.